Characteristics, outcomes and treatments of adults aged ≥ 65 years admitted to rehabilitation or long-term care hospitals with COVID-19*
| Characteristic | No. (%) of patients† n = 115 |
|---|---|
| Age, yr, median (IQR) | 86.0 (78.5–91.0) |
| Female | 72 (62.6) |
| Rehabilitation hospital | 44 (38.3) |
| Long-term care | 71 (61.7) |
| Clinical Frailty Scale | |
| Mean score ± SD | 6.80 ± 1.17 |
| Frail (score ≥ 5) | 109 (94.8) |
| Comorbidities | |
| Dementia | 56 (48.7) |
| Falls | 53 (46.1) |
| Heart failure | 17 (14.8) |
| Coronary artery disease | 27 (23.5) |
| Chronic kidney disease | 13 (11.3) |
| Stroke | 21 (18.3) |
| Hypertension | 68 (59.1) |
| Diabetes | 38 (33.0) |
| Chronic obstructive pulmonary disease | 9 (7.8) |
| Cancer | 25 (21.7) |
| Presenting characteristics | |
| Any infiltrate on chest x-ray | 7 (6.1) |
| Maximum temperature on presentation, °C, median (IQR) | 37.5 (36.9–38.0) |
| Outcomes | |
| In-hospital death | 28 (24.3) |
| Delirium | 17 (14.8) |
| Any complications | 44 (38.3) |
| Complications | |
| Fall | 19 (16.5) |
| Pneumonia | 16 (13.9) |
| Aspiration | 2 (1.7) |
| Respiratory failure | 8 (7.0) |
| Acute respiratory distress syndrome | 4 (3.5) |
| Use of restraints | 0 (0) |
| Treatments | |
| Dexamethasone | 25 (21.7) |
| Azithromycin | 7 (6.1) |
| Other antibiotics | 16 (13.9) |